Users Discontinuing Slimming Injections Regain Weight at a Quadrupled Rate Than Those on Conventional Diets

New research reveals that individuals who discontinue popular slimming jabs like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who stop traditional diet and exercise regimens.

Published data in a leading health publication points out that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month once they quit.

"People purchasing these medications must be informed of the potential of fast weight regain when the medication concludes," warns expert Dr. Susan Jebb.

This pace of regain suggests a reversion to pre-treatment weight within about 18 months.

Weighing Approaches

The study, which reviewed 37 of trials involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.

Scientists point out that individuals who lose weight through diet and exercise usually have a slower creep back—approximately 0.1 kg a month—once they finish.

Explaining the Rapid Regain

Experts believe the way of the injections is key to understanding the accelerated rebound.

The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Artificially providing GLP-1 concentrations several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating a significant risk."

A Chronic Disease?

Medical guidelines advise the injections for people with obesity-related health risks, alongside recommended lifestyle changes.

Professionals say that, due to the likelihood of weight regain, the treatment might need to be ongoing.

This opinion is reinforced by drug manufacturers, who say that the results "emphasize the long-term nature of excess weight," comparing it to managing conditions like hypertension.

User Testimonies

Users who have come off the jabs explain a sudden return of cravings.

"It was like a trigger activating and you become extremely hungry," said a patient.

The struggle is worsened if users have not adopted permanent dietary or behavioural changes during therapy.

Growing Interest

Recent estimates show that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest being substantial.

• Adoption is greater among females than men.
• The 40s and 50s demographic shows the greatest usage rates.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

In conclusion, researchers stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone fix and long-term success relies on combined behavioural support.